tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Korro Bio reports Q2 EPS ($2.74), consensus ($2.59)
PremiumThe FlyKorro Bio reports Q2 EPS ($2.74), consensus ($2.59)
2M ago
Buy Rating for Korro Bio Driven by Promising KRRO-110 and Orphan Drug Designation
Premium
Ratings
Buy Rating for Korro Bio Driven by Promising KRRO-110 and Orphan Drug Designation
2M ago
Korro Bio receives European Medicines Agency granted ODD for KRRO-110
Premium
The Fly
Korro Bio receives European Medicines Agency granted ODD for KRRO-110
2M ago
Korro Bio price target lowered to $53 from $130 at H.C. Wainwright
PremiumThe FlyKorro Bio price target lowered to $53 from $130 at H.C. Wainwright
5M ago
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
Premium
The Fly
Korro Bio price target lowered to $100 from $115 at H.C. Wainwright
5M ago
Strategic Workforce Restructuring and Clinical Advancements Justify Buy Rating for Korro Bio
Premium
Ratings
Strategic Workforce Restructuring and Clinical Advancements Justify Buy Rating for Korro Bio
5M ago
Korro Bio initiated with a Buy at Chardan
PremiumThe FlyKorro Bio initiated with a Buy at Chardan
5M ago
Korro Bio appoints Loic Vincent as Chief Scientific Officer
Premium
The Fly
Korro Bio appoints Loic Vincent as Chief Scientific Officer
6M ago
Korro Bio CFO Returns from Medical Leave
Premium
Company Announcements
Korro Bio CFO Returns from Medical Leave
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100